Results 161 to 170 of about 91,338 (344)

ANALYSIS OF LOSS OF HETEROZYGOSITY (LOH) AT THE p53 AND Rb SUPPRESSOR GENES IN URINARY BLADDER CARCINOMA

, 1994
Hiroshi Tamada, Yasushi Suzuki, Gen Tamura   +2 more
openalex   +2 more sources

Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia [PDF]

, 1998
Kenji Suzuki, Tsutomu Ogura, Tomoyuki Yokose, Kanji Nagai, Kiyoshi Mukai, Tetsuro Kodama, Y Nishiwaki, Hiroyasu Esumi   +7 more
openalex   +1 more source

Evolution of loss of heterozygosity patterns in hybrid genomes of Candida yeast pathogens. [PDF]

BMC Biol, 2023
Mixão V, Nunez-Rodriguez JC, Del Olmo V, Ksiezopolska E, Saus E, Boekhout T, Gacser A, Gabaldón T.   +7 more
europepmc   +1 more source

Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma [PDF]

, 1998
Cinzia Lavarino, Valentina Corletto, Alessandra Mezzelani, Gabriella Della Torre, Cesare Bartoli, Catherine Riva, Marco A. Pierotti, Franco Rilke, S. Pilotti   +8 more
openalex   +1 more source

Imprinted survival genes preclude loss of heterozygosity of chromosome 7 in cancer cells

Journal of Pathology, 2016
Arnoud Boot, J. Oosting, N. D. de Miranda, Yinghui Zhang, W. Corver, B. van de Water, H. Morreau, T. van Wezel   +7 more
semanticscholar   +1 more source

TBX3‐ Related Disorder

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Heterozygous pathogenic variants in TBX3 cause Ulnar‐Mammary syndrome (UMS). The phenotype is classically characterized by upper limb defects, apocrine/mammary gland hypoplasia, hypogonadism, and various midline defects. However, the clinical spectrum is highly variable, and some individuals may present with a mild or atypical presentation ...
Ziv Halperin, Karin Weiss
wiley   +1 more source

Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma. [PDF]

Cancers (Basel), 2023
Bartow BB, Siegal GP, Yalniz C, Elkhanany AM, Huo L, Ding Q, Sahin AA, Guo H, Magi-Galluzzi C, Harada S, Huang X.   +10 more
europepmc   +1 more source

Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma [PDF]

, 1998
Laura De Gregorio, Giacomo Manenti, Matteo Incarbone, Silvana Pilotti, Ugo Pastorino, Marco A. Pierotti, Tommaso A. Dragani   +6 more
openalex   +1 more source

De Novo Heterozygous ZFX Frameshift Variant in a Female With an X‐Linked Neurodevelopmental Disorder

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Germline ZFX variants are associated with an X‐linked neurodevelopmental disorder, with 14 males and 16 females reported to date. We describe a 20‐year‐old female with a heterozygous ZFX frameshift variant, p.(Met666Valfs*2), identified by genome sequencing, previously reported in an affected male.
Iftekhar A. Showpnil, Allison Daley, Emily R. Sites, Shayne M. Plourde, Jesse M. Hunter, Dennis W. Bartholomew, April N. Lehman, Daniel C. Koboldt, Rolf W. Stottmann   +8 more
wiley   +1 more source

BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer [PDF]

, 1999
Τοyoaki Uchida, Xue Wang, T. Sato, Jiangping Gao, Rikiya Takashima, Akira Irie, Makoto Ohori, Ken Koshiba   +7 more
openalex   +1 more source